Abstract:Background: Basal ganglia and thalamic arteriovenous malformations (AVMs) represent a special subset of malformations. Due to the involvement of vital brain structures and the specifically fine and delicate angioarchitecture of these lesions, it presents unique therapeutic challenges and technical difficulties that require thorough treatment planning, individualized treatment strategies, and advanced techniques for good clinical outcome. Method: In this study, we presented a series of ruptured basal ganglia and thalamic AVMs embolized via a transarterial, transvenous or combined approach. Herein, we summarized our treatment experience and clinical outcomes to further evaluate the effectiveness and safety of endovascular embolization for these AVMs as well as the indications, therapy strategies, and techniques of embolization procedures. Results: Twelve patients with basal ganglia and thalamus AVMs were included in the study. Their average age was 23.83 ± 16.51 years (range, 4–57 years) with a female predominance of 67% at presentation. The AVMs were located in the thalamus in 3 (25%) patients, in the basal ganglia in 3 (25%) patients, and in both sites of the brain in 6 (50%) patients. There were 5 AVMs located on the left side and 7 on the right. The mean nidus diameter was 3.32 ± 1.43 cm (range 1.3–6.1 cm). According to the Spetzler-Martin grading classification, 4 (33.3%) brain AVMs were Grade III, 7 (58.3%) were Grade IV, and 1 (8.3%) was Grade V. All of them presented with bleeding at admission: four of these patients presented with an intracerebral hemorrhage (ICH), 8 ICH in combination with intraventricular hemorrhage (IVH), and no patient with subarachnoid hemorrhage (SAH). Among these patients treated with endovascular embolization, 7 patients were treated by the transarterial approach, 4 patients transvenous approach, and 1 patient underwent the combined approach. A single embolization procedure was performed in 6 patients (50%) and the other 6 cases (50%) were treated in a staged manner with up to three procedures. Procedure-related complications occurred only in two patient (16.7%). Complete AVM obliteration was obtained in 7 patients (58.3%), and partial obliteration was in 4 patients (33.3%). Overall, good or excellent outcomes were obtained in 7 patients (58.3%), and poor functional outcome was observed in 5 patients (41.7%) at the last follow-up. All survived patients achieved anatomic stabilization and there was no postoperative bleeding or recurrence in the follow-up. Conclusion: The management of the basal ganglia and thalamic AVMs is a great challenge, which needs multimodal individualized treatment to improve the chances of radiographic cure and good outcomes. Endovascular therapy is safe and effective in the treatment of cerebral AVMs particularly for deep-seated AVMs such as the basal ganglia and thalamus. Our results demonstrate a high rate of anatomic obliteration with an acceptable rate of complications in the endovascular treatment of these vasculopathies via a transarterial approach or a transvenous approach.

Histopathological and immunohistochemical studies of cerebral arteriovenous malformations after intravascular embolization

Relationship of Bleeding Complications and Impairment of Draining Veins after Α-N-butyl Cyanoacrylate Embolization of Brain Arteriovenous Malformations

Study of angioarchitectural factors and their correlation with bleeding risk of intracranial arteriove-nous malformations

Effect of transcatheter arterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor in cervical squamous cell carcinoma

Histopathology study of cerebral arteriovenous malformations after stereostactic gamma knife radiosurgery(Report of 5 cases)

The micro-pathological characteristics in cerebral arteriovenous malformations(cAVMs)

Microsurgical Excision Combined with Preoperational Endovascular Embolization in Treatment of Cerebral Arteriovenous Malformation

Detection of VEGF Expression in Cultured Human Cerebral Arteriovenous Malformation Vascular Endothelial Cellsin Vitro

Expression of osteopontin and its significance in human cerebral arteriovenous malformations.

Recurrence of Cerebral Arteriovenous Malformation Following Complete Obliteration Through Endovascular Embolization

Application of embolization for arteriovenous malformations of the soft tissue in oral and maxillofacial region

Cerebral Arteriovenousmalformation Embolization Prevention of Postoperative Complications

Effects of Vascular Endothelial Growth Factor on Angiogenesis of the Endothelial Cells Isolated from Cavernous Malformations

Pressure cooker technique for curative embolization of intracranial arteriovenous malformation

Key biomarkers in cerebral arteriovenous malformations: Updated review

Phenotypic Modulation of Vascular Smooth Muscle Cells in Cerebral Arteriovenous Malformations

A Preliminary Study of Angioarchitecture and Treatment of Soft Tissue Arteriovenous Malformations in Oral and Maxillofacial Region

Quantitative evaluation of hemodynamics after partial embolization of brain arteriovenous malformations

Immunohistochemical Study on Central Nervous System Cavernous Hemangiomas

Spontaneous Thrombosis in Main Draining Veins of Unruptured Cerebral Arteriovenous Malformations

Endovascular embolization for basal ganglia and thalamic arteriovenous malformations